Overview of the fibrinolytic system

被引:0
作者
Rijken, DC [1 ]
机构
[1] TNO, IVVO, Gaubius Lab, NL-2300 AK Leiden, Netherlands
来源
THROMBOSIS: FUNDAMENTAL AND CLINICAL ASPECTS | 2003年
关键词
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:163 / +
页数:16
相关论文
共 65 条
[1]  
BACHMANN F, 2001, HDB EXPT PHARM, V146
[2]   An antifibrinolytic mechanism describing the prothrombotic effect associated with factor V-Leiden [J].
Bajzar, L ;
Kalafatis, M ;
Simioni, P ;
Tracy, PB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (38) :22949-22952
[3]   PURIFICATION AND CHARACTERIZATION OF TAFI, A THROMBIN-ACTIVABLE FIBRINOLYSIS INHIBITOR [J].
BAJZAR, L ;
MANUEL, R ;
NESHEIM, ME .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (24) :14477-14484
[4]   The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent [J].
Bajzar, L ;
Nesheim, ME ;
Tracy, PB .
BLOOD, 1996, 88 (06) :2093-2100
[5]   Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U) [J].
Bouma, BN ;
Meijers, JCM .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (07) :1566-1574
[6]  
Bouma BN, 1998, THROMB HAEMOSTASIS, V80, P24
[7]   A novel, possibly functional, single nucleotide polymorphism in the coding region of the thrombin-activatable fibrinolysis inhibitor (TAFI) gene is also associated with TAFI levels [J].
Brouwers, GJ ;
Vos, HL ;
Leebeek, FWG ;
Bulk, S ;
Schneider, M ;
Boffa, M ;
Koschinsky, M ;
van Tilburg, NH ;
Nesheim, ME ;
Bertina, RM ;
García, EBG .
BLOOD, 2001, 98 (06) :1992-1993
[8]   Coagulation-dependent inhibition of fibrinolysis: Role of carboxypeptidase-U and the premature lysis of clots from hemophilic plasma [J].
Broze, GJ ;
Higuchi, DA .
BLOOD, 1996, 88 (10) :3815-3823
[10]  
Chandler WL, 1997, CIRCULATION, V96, P761